Found 30 matching trials
ADIponectin and Asymmetric Dimethylarginine (ADMA) Level in Type-2 Diabetes Patients After 12 Weeks of Treatment With GlimepiRide And Metformin Fixed Dose Combination PHASE4 Primary Objective:
To evaluate the change in plasma levels of adiponectin ...
Show More Location
Sanofi-Aventis Administrative Office
Learn More & Join Trial
Dose Proportionality Study About Amaryl M Slow Release (SR) 1/500 mg PHASE1 The pharmacokinetics of glimepiride and metformin will be compared after si...
Show More Location
Seoul National University Hospital
Learn More & Join Trial
Comparison of Hypoglycaemic Regimens During Ramadan Fasting in Type 2 Diabetes NA Type 2 diabetic patients who fast during Ramadan experience swings in glyca...
Show More Location
Endocrinology Unit & Diabetes Management Centre, Services Hospital.
Learn More & Join Trial
Comparative Study of HOE490 O (Glimepiride and Metformin) Compared With Placebo on Top of Glimepiride PHASE3 Primary objective of this study is to confirm the efficacy of HOE490 O (gli...
Show More Location
Sanofi-Aventis Administrative Office
Learn More & Join Trial
Efficacy/Safety Study of Amaryl®M 1/500 mg Twice Daily Versus Amaryl® 4 mg Both in Combination With Lantus® in Type 2 Diabetes Mellitus PHASE4 The purpose of this study is to compare the efficacy of Amaryl®M 1/500 mg t...
Show More Learn More & Join Trial
COMPOUND (INN): HOE490O - GLIMEPIRIDE / METFORMIN HCl (Amaryl® M)0 (Glimepiride/Metformin Hydrochloride Immediate Release Combination Tablet) in Fed Conditions in Healthy Male and/or Female Subjects. PHASE1 The purpose of this study is to assess, after single oral administration un...
Show More Location
Arab Pharmaceutical industry Consulting/ Pharmaceutical Research Unit
Learn More & Join Trial
Triple Combination Therapy in Type 2 Diabetic Patients Who Had Inadequate Glycemic Control With Combination Therapy PHASE4 To assess the efficacy of treatment with sitagliptin or dapagliflozin or lo...
Show More Learn More & Join Trial
Efficacy and Safety Comparison of Metformin/Glimepiride Combination Versus Each Compound Alone in New Diagnosed Type 2 Diabetes Patients PHASE3 Primary Objective:
\- To demonstrate the superiority of glimepiride and me...
Show More Location
Investigational Site Number 01206
Learn More & Join Trial
Addition of Omarigliptin (MK-3102) to Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Combination Therapy With Glimepiride and Metformin (MK-3102-022) PHASE3 This study will examine the safety and efficacy of the addition of omarigli...
Show More Location
Multiple Locations
Learn More & Join Trial
Study To Evaluate Beta Cell Function and Glycemic Outcome by Intensive Insulin Therapy PHASE4 This randomized controlled prospective study aims to evaluate the efficacy ...
Show More Location
Hanyang University Medical Center
Learn More & Join Trial